相关实验视频
Updated: Jan 8, 2026

07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
13.1K
评估MEL-SELF试验分析患者主导的早期黑色素瘤监测缺失结果数据方法:模拟研究
Ellie Medcalf1, Robin M Turner2, David Espinoza3
1Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Contemporary clinical trials
|December 17, 2025
概括
对于缺少结果数据的黑色素瘤试验,检索掉队 (RD) 归算将偏差从零最小化,而跳转到参考 (J2R) 归算将偏差向零最小化.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 医学研究 医学研究
背景情况:
- 完整病例分析 (CCA) 是一种常见但潜在偏见的方法,用于处理临床试验中缺少的结果数据.
- 解决缺失的非随机 (MNAR) 数据的先进方法未得到充分利用.
研究的目的:
- 在模拟黑色素瘤监测试验中评估六种不同缺失数据处理方法的性能.
- 在各种缺失数据场景下,比较常用的方法 (CCA,MMRM,MI) 与较新的方法 (RD,J2R,TM).
主要方法:
- 一项基于MEL-SELF试点试验的模拟研究,用于早期黑色素瘤患者主导的监测.
- 评估完整案例分析 (CCA),重复测量混合模型 (MMRM),多重推算 (MI),检索掉落 (RD) 推算,跳到参考 (J2R) 推算和修剪平均值 (TM).
- 场景包括治疗效果的大小,失踪率和失踪假设 (共48个场景).
主要成果:
- 在MNAR条件下,治疗效果小到中等,所有方法都显示出偏差. 修剪平均值 (TM) 和CCA分别表现出最偏向于和偏离零值,精度和功率较低.
- 跳转至参考 (J2R) 归算在偏向于零的方法中表现最好,显示最小偏差,高精度和良好的覆盖率.
- 在偏离零值的方法中,检索失效 (RD) 归算表现最好,表现出小偏差,良好的精度和足够的覆盖.
结论:
- 在非随机缺失结果的黑色素瘤监测试验中,RD归算产生了最少偏离零的偏差.
- 在这个模拟研究中,J2R归算提供了对零值的最小偏差.
相关概念视频
Kaplan-Meier Approach
536
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
536
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Assumptions of Survival Analysis
382
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
382
Comparing the Survival Analysis of Two or More Groups
533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533
Actuarial Approach
276
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
276

